Alzheimer's Association Develops First Practice Guidelines for Clinical Evaluation of Alzheimer Disease, Other Dementias
The recommendations will provide an important tool to help improve the quality of the diagnostic process, so patients receive an early and accurate diagnosis.
FDA Accepts Galcanezumab Application for Migraine Prevention
The FDA has accepted a biologics license application for galcanezumab as a prophylactic treatment for migraines.